Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about MERCK & CO., INC.
09:15aMERCK & CO., INC. : quaterly earnings release
08:03aMERCK : Donates $500,000 to Support River Blindness and Lymphatic Filariasis Eli..
BU
05:45aCovid-19 Vaccine Makers to Face Challenges When Recognizing Revenue
DJ
10/21MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
AQ
10/21MERCK : to Present New Data from its Extensive Infectious Diseases and Vaccines ..
BU
10/20MERCK : and Sanofi to Present Three New Studies Highlighting Combination Pediatr..
PU
10/20MERCK : Reports More Positive Phase 3 Study Results for V114 Vaccine
DJ
10/20MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
BU
10/16MERCK : Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combi..
BU
10/16MERCK : FDA Approves Expanded Indication for Merck's KEYTRUDA in Adult Patients ..
AQ
10/15MERCK : Issues 2019, 2020 Corporate Responsibility Report
AQ
10/15MERCK : Gets FDA Expanded Approval for Keytruda in Classical Hodgkin Lymphoma
DJ
10/15MERCK : Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment..
AQ
10/15MERCK : FDA Approves Expanded Indication for Merck's KEYTRUDA® (pembrolizumab) i..
BU
10/14MERCK : Announces Plans to Construct New Facility in the United States to Expand..
PU
More most relevant news
All news about MERCK & CO., INC.
09:15aMERCK & CO., INC. : quaterly earnings release
08:03aMERCK : Donates $500,000 to Support River Blindness and Lymphatic Filariasis Eli..
BU
05:45aCovid-19 Vaccine Makers to Face Challenges When Recognizing Revenue
DJ
10/21MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
AQ
10/21SANOFI : Merck and Sanofi to Present Three New Studies Highlighting Combination ..
AQ
10/21MERCK : to Present New Data from its Extensive Infectious Diseases and Vaccines ..
BU
10/20MERCK : and Sanofi to Present Three New Studies Highlighting Combination Pediatr..
PU
10/20MERCK : Reports More Positive Phase 3 Study Results for V114 Vaccine
DJ
10/20MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
BU
10/16MERCK : Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combi..
BU
More news
News in other languages on MERCK & CO., INC.
02:45aMERCK & CO., INC. : Veröffentlichung des Quartalsergebnisses
02:45aMERCK & CO., INC. : publication des résultats trimestriels
10/21MERCK : va partager les résultats de ses recherches
10/20MERCK : essais encourageants du vaccin anti-pneumococcique
10/15MERCK : des progrès dans le traitement du lymphome hodgkinien
10/08MERCK : résultats encourageants pour un traitement du VIH
10/02MERCK : changement à la tête du laboratoire de recherche
10/01Fachjournale werfen US-Arzneimittelbehörde FDA Nachlässigkeit vor
09/28MERCK : lance une campagne mondiale contre la rage
09/14US-Konzern Merck & Co steigt für Krebsmittelforschung bei Seattle Genetics ei..
Analyst Recommendations on MERCK & CO., INC.
01/07MERCK & CO INC : RBC gives a Neutral rating
MD
2019MERCK & CO INC : Goldman Sachs remains Neutral
MD
2019MERCK & CO INC : JP Morgan remains Neutral
MD
2017Germany's Merck hires JP Morgan to sell consumer health
RE
More recommendations
Press releases
08:03aMERCK : Donates $500,000 to Support River Blindness and Lymphatic Filariasis Eli..
BU
10/21SANOFI : Merck and Sanofi to Present Three New Studies Highlighting Combination ..
AQ
10/21MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
AQ
10/21MERCK : to Present New Data from its Extensive Infectious Diseases and Vaccines ..
BU
10/20MERCK : and Sanofi to Present Three New Studies Highlighting Combination Pediatr..
PU
More press releases
Upcoming event on MERCK & CO., INC.